Life ScienceCompany
Tetraphase Pharmaceuticals Ownership
Who owns Tetraphase Pharmaceuticals?
Tetraphase Pharmaceuticals is owned by La Jolla Pharmaceutical. It was acquired on June 24, 2020.
Was Tetraphase Pharmaceuticals formerly PE-backed?
Yes. Tetraphase Pharmaceuticals was formerly owned by 2 private investors.
Tetraphase Pharmaceuticals Business Overview
Where is Tetraphase Pharmaceuticals headquartered?
Tetraphase Pharmaceuticals is headquartered in Watertown, Massachusetts.
What is Tetraphase Pharmaceuticals’ revenue?
Tetraphase Pharmaceuticals disclosed revenue of 7M USD for 2019 and 19M USD for 2018.
How many employees does Tetraphase Pharmaceuticals have?
Tetraphase Pharmaceuticals has 119 employees.
What sector is Tetraphase Pharmaceuticals in?
Tetraphase Pharmaceuticals is a life science company.
When was Tetraphase Pharmaceuticals founded?
Tetraphase Pharmaceuticals was founded in 2006.
Life Science M&A Summary in 2020
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2020. The largest life science acquisition in 2020 was Alexion Pharmaceuticals - which was acquired by AstraZeneca for $39.0B.
Join Mergr to view all 285 acquisitions of life science companies in 2020, including 23 acquisitions by private equity firms, and 262 by strategics.